cas: 315183-21-2 — see every product listed under this CAS number, including other names
PAC–1 (CAS 315183-21-2) is a chemical reagent available from Chemat. Available pack sizes: 10mg, 100mg, 25mg, 250mg, 10mM (in 1ml dmso), 50mg. Offered by: GLPBio.
| brand | GLPBio |
|---|---|
| catalog number | GC11993-10 |
| cas | 315183-21-2 |
| size | 10mg |
Ask us about this product — we're happy to help.
| brand | size | price | |
|---|---|---|---|
| GLPBio | 10mg | 573.64 Pln | |
| GLPBio | 100mg | 1219.55 Pln | |
| GLPBio | 25mg | 671.93 Pln | |
| GLPBio | 250mg | 2801.56 Pln | |
| GLPBio | 10mM (in 1ml dmso) | 587.68 Pln | |
| GLPBio | 50mg | 896.59 Pln |
| purity | No data |
|---|---|
| delivery time | To be confirmed by Chemat |
Pac-1 is procaspase Activating Compound-1 VO-100 is an orally bioavailable procaspase activating compound-1 (PAC-1), with potential proapoptotic and antineoplastic activities. Upon administration, VO-100 binds to and forms a chelating complex with zinc (Zn) ions inside cells, which prevents the binding of Zn ions to procaspase-3 (PC3) and abrogates the Zn-mediated inhibition of PC3. This allows for the proteolytic autoactivation of PC3 into the active form caspase-3. This results in the selective caspase-3-mediated induction of apoptosis and cell death in cancer cells. In addition, VO-100 is able to cross the blood-brain-barrier (BBB). PC3, a Zn-inhibited proenzyme, is upregulated in a variety of cancer cell types, while its expression is minimal in normal healthy cells.
Source: ChEBI
| Molecular formula | C23H28N4O2 |
|---|---|
| Molecular weight | 392.5 g/mol |
| IUPAC name | 2-(4-benzylpiperazin-1-yl)-N-[(E)-(2-hydroxy-3-prop-2-enylphenyl)methylideneamino]acetamide |
| InChIKey | YQNRVGJCPCNMKT-LFVJCYFKSA-N |
| SMILES | C=CCC1=C(C(=CC=C1)/C=N/NC(=O)CN2CCN(CC2)CC3=CC=CC=C3)O |
Computed by PubChem (NCBI)